The role of epidermal growth factor receptor and E-cadherin for the outcome of reduction in the overall treatment time of radiotherapy of supraglottic larynx squamous cell carcinoma

References

• Overgaard J, Alsner J, Eriksen J, et al. Importance of overall treatment time for the response to radiotherapy in patients with squamous cell carcinoma of the head and neck. Rays 2000;25:313–9.
   PubMedGoogle Scholar
• Withers HR, Taylor JM, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiother-apy. Acta Oncol 1988;27:131–46.
   Google Scholar
• Bentzen SM, Johansen LV, Overgaard J, et al. Clinical radiobiology of squamous cell carcinoma of the oropharynx. Int J Radiat Oncol Biol Phys 1991;20:1197–206.
   PubMed Web of Science ®Google Scholar
• Hliniak A, Gwiazdowska B, Szutkowski Z, et al. A multi-centre randomized/controlled trial of a conventional versus modestly accelerated radiotherapy in the laryngeal cancer: influence of a 1 week shortening overall time. Radiother Oncol 2002;62:1–10.
   PubMed Web of Science ®Google Scholar
• Skladowski K, Maciejewski B, Golen M, et al. Randomized clinical trial on 7-day-continuous accelerated irradiation (CAIR) of head and neck cancer - report on 3-year T-site control and normal tissue toxicity. Radiother Oncol 2000;55: 101–10.
   PubMed Web of Science ®Google Scholar
• Overgaard J, Hansen HS, Specht L, et al. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial. Lancet 2003;362:933–40.
   PubMed Web of Science ®Google Scholar
• Grau C, Hansen HS, Specht L, et al. Acute and late normal tissue reactions in the DAHANCA 6&7 randomized trial with accelerated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2003;57:5154.
   Google Scholar
• Maciejewski B, Skladowski K, Pilecki B, et al. Randomized clinical trial on accelerated 7 days per week fractionation in radiotherapy for head and neck cancer. Preliminary report on acute toxicity. Radiother Oncol 1996;40:137–45.
   Google Scholar
• Overgaard J, Hansen HS, Overgaard M, et al. Importance of overall treatment time for the outcome of radiotherapy in head and neck carcinoma. Experience from the Danish Head and Neck Cancer Study. In: Kogelnik HD, Sedelmayer F, editors. Progress in radio-oncology IV. Bologna: Monduzzi Editore; 1998. p. 743–52.
   Google Scholar
• Hansen O, Overgaard J, Hansen HS, et al. Importance of overall treatment time for the outcome of radiotherapy of advanced head and neck carcinoma: dependency on tumor differentiation. Radiother Oncol 1997;43:47–51.
   PubMed Web of Science ®Google Scholar
• Bryne M, Koppang HS, Lilleng R, et al. New malignancy grading is a better prognostic indicator than Broders' grading in oral squamous cell carcinomas. J Oral Pathol Med 1989;18:432–7.
   PubMed Web of Science ®Google Scholar
• Anneroth G, Batsakis J, Luna M. Review of the literature and a recommended system of malignancy grading in oral squamous cell carcinomas. Scand J Dent Res 1987;95:229–49.
   Google Scholar
• McLaren KM, Burnett RA, Goodlad JR, et al. Consistency of histopathological reporting of laryngeal dysplasia. Histo-pathology 2000;37:460–3.
   Google Scholar
• Sawair FA, Irwin CR, Gordon DJ, et al. Invasive front grading: reliability and usefulness in the management of oral squamous cell carcinoma. J Oral Pathol Med 2003;32:1–9.
   PubMed Web of Science ®Google Scholar
• Dassonville O, Formento JL, Francoual M, et al. Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer. J Chin Oncol 1993;11:1873–8.
   PubMed Web of Science ®Google Scholar
• O-Charoenrat P, Rhys-Evans P, Modjtahedi H, et al. The role of c-erbB receptors and ligands in head and neck squamous cell carcinoma. Oral Oncol 2002;38:627–40.
   Google Scholar
• O-Charoenrat P, Rhys-Evans PH, Archer DJ, et al. C-erbB receptors in squamous cell carcinomas of the head and neck: clinical significance and correlation with matrix metallopro-teinases and vascular endothelial growth factors. Oral Oncol 2002;38:73–80.
   Google Scholar
• Huang SM, Harari PM. Epidermal growth factor receptor inhibition in cancer therapy: biology, rationale and preli-minary clinical results. Invest New Drugs 1999;17:259–69.
   PubMed Web of Science ®Google Scholar
• Ang KK, Berkey BA, Tu X, et al. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res 2002;62:7350–6.
   PubMed Web of Science ®Google Scholar
• Eriksen JG, Steiniche T, Alsner J, et al. The prognostic value of epidermal growth factor receptor is related to tumor differentiation and the overall treatment time of radiotherapy in squamous cell carcinomas of the head and neck. hit J Radiat Oncol Biol Phys 2004;58:561–6.
   PubMed Web of Science ®Google Scholar
• Trott KR. The mechanisms of acceleration of repopulation in squamous epithelia during daily irradiation. Acta Oncol 1999;38:153–7.
   PubMed Web of Science ®Google Scholar
• Jongen WM, Fitzgerald DJ, Asamoto M, et al. Regulation of connexin 43-mediated gap junctional intercellular commu-nication by Ca2+ in mouse epidermal cells is controlled by E- cadherin. J Cell Biol 1991;114:545–55.
   PubMed Web of Science ®Google Scholar
• Guilford P. E-cadherin downregulation in cancer: fuel on the fire? Mol Med Today 1999;5:172–7.
   PubMedGoogle Scholar
• Andrews NA, Jones AS, Helliwell TR, et al. Expression of the E-cadherin—catenin cell adhesion complex in primary squamous cell carcinomas of the head and neck and their nodal metastases. Br J Cancer 1997;75:1474–80.
   PubMed Web of Science ®Google Scholar
• Herbst RS, Langer CJ. Epidermal growth factor receptors as a target for cancer treatment: the emerging role of I1\'IC-C225 in the treatment of lung and head and neck cancers. Semin Oncol 2002;29:27–36.
   PubMed Web of Science ®Google Scholar
• Rodrigo JP, Dominguez F, Alvarez C, et al. Expression of E-cadherin in squamous cell carcinomas of the supraglottic larynx with correlations to clinicopathological features. Eur J Cancer 2002;38:1059–64.
   PubMed Web of Science ®Google Scholar
• Hodivala KJ, Watt FM. Evidence that cadherins play a role in the downregulation of integrin expression that occurs during keratinocyte terminal differentiation. J Cell Biol 1994;124:589–600.
   PubMed Web of Science ®Google Scholar
• Perl AK, Wilgenbus P, Dahl U, et al. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 1998;392:190–3.
   PubMed Web of Science ®Google Scholar
• Lund C, Sogaard H, Jorgensen K, et al. Histological grading of epidermoid carcinomas in the head and neck. Dan Med Bull 1977;24:162–6.
   PubMed Web of Science ®Google Scholar
• Eriksen JG, Steiniche T, Sogaard H, Overgaard J. Expression of integrins and E-cadherin in squamous cell carcinomas of the head and neck. APMIS, accepted 2004.
   Google Scholar
• Al Moustafa AE, Yansouni C, Alaoui-Jamali MA, et al. Up-regulation of E-cadherin by an anti-epidermal growth factor receptor monoclonal antibody in lung cancer cell lines. Chin Cancer Res 1999;5:681–6.
   Google Scholar
• Christensen ME. The EGF receptor system in head and neck carcinomas and normal tissues. Dan Med Bull 2003; 45:121–34.
   Google Scholar
• Mattijssen V, Peters HM, Schalkwijk L, et al. E-cadherin expression in head and neck squamous-cell carcinoma is associated with clinical outcome. Int J Cancer 1993;55: 580–5.
   PubMed Web of Science ®Google Scholar
• Huang SM, Bock JM, Harari PM. Epidermal growth factor receptor blockade with C225 modulates proliferation, apop-tosis, and radiosensitivity in squamous cell carcinomas of the head and neck. Cancer Res 1999;59: 1935–40.
   Google Scholar
• Schmidt-Ullrich RK, Mikkelsen RB, Dent P, et al. Radia-tion-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphor-ylation. Oncogene 1997;15: 1191–7.
   Google Scholar
• Lu Z, Ghosh S, Wang Z, et al. Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion. Cancer Cell 2003;4:499–515.
   PubMed Web of Science ®Google Scholar
• Deeb G, Wang J, Ramnath N, et al. Altered E-cadherin and epidermal growth factor receptor expressions are associated with patient survival in lung cancer: a study utilizing high-density tissue microarray and immunohistochemistry. Mod Pathol 2004; January: e-publication.
   Google Scholar
• Inada S, Koto T, Futami K, et al. Evaluation of malignancy and the prognosis of esophageal cancer based on an immunohistochemical study (p53, E-cadherin, epidermal growth factor receptor). Surg Today 1999;29:493–503.
   PubMed Web of Science ®Google Scholar